To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.
Sponsored By: Representative Morelle, Joseph D. [D-NY-25]
Introduced
Summary
No summary available.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Morelle, Joseph D. [D-NY-25]
NY • D
Cosponsors
Rep. Gottheimer, Josh [D-NJ-5]
NJ • D
Sponsored 5/15/2026
Pfluger
TX • R
Sponsored 5/15/2026
Kean
NJ • R
Sponsored 5/15/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov